Hawthorn: Clinical Trials

4 trials of Hawthorn, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 2 Not applicable, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2
Phase 11Completed 1
Phase 41Completed 1

Follow Hawthorn: new trials by email Literature Review of Hawthorn trials Research Report on Hawthorn

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Effect of Hawthorn on Lipoprotein Cholesterol Ratio in Schizophrenics With Antipsychotics
Hawthorn, SGAs - Schizophrenia
Not applicableCompletedCalo Psychiatric Center1352013-01-012018-09-10
Role of a Combination of Nutraceuticals (Ritmonutra) on Benign Supraventricular and Ventricular Arrhythmias
Ritmonutra, placebo - Ventricular and Atrial Extrasytoles
Phase 4CompletedFederico II University15002012-12-012016-02-03
Nitric Oxide Mediated Vasodilatory Response to Hawthorn Standardized Extract
Hawthorn, Placebo capsule - Prehypertension, Mild Hypertension
Phase 1CompletedUniversity of North Carolina, Chapel Hill242010-05-012013-02-07
Pharmacokinetic and Pharmacodynamic Interaction Study of Digoxin and Hawthorn
Digoxin, Hawthorn - Heart Diseases
Not applicableCompletedNational Center for Research Resources (NCRR)2005-06-24

Conditions studied

Arrhythmias, Cardiac (1)  ·  Dyslipidemias (1)  ·  Heart Diseases (1)  ·  Prehypertension (1)  ·  Schizophrenia (1)

Sponsors

Calo Psychiatric Center (1)  ·  Federico II University (1)  ·  National Center for Research Resources (NCRR) (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (2)  ·  Italy (1)

Top investigators

Bruno Trimarco, MD (1)  ·  Gary N Asher, MD, MPH (1)

Results publications

PMID 20498621, PMID 22458601

NIH funding

M01RR000042 (1)